v3.25.2
Segment Information - Schedule of Business Segments (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Segment Reporting Information [Line Items]          
Net sales $ 2,532 $ 2,651 $ 4,921 $ 5,262  
Cost of sales (1,997) (2,010) (3,910) (4,067)  
Gross profit 535 641 1,011 1,195  
Selling, general and administrative expenses (213) (255) (443) (520)  
Amortization of intangible assets (42) (38) (82) (79)  
Research and development expenses (31) (33) (62) (67)  
Other (charges) gains, net (Note 18) (20) (48) (51) (62)  
Gain (loss) on disposition of business and assets, net (2) (8) 1 (9)  
Other segment items(2) 6 [1] (9) [1] 27 [2] 2 [2]  
Operating profit (loss) 233 250 401 460  
Depreciation and amortization 190 192 370 413  
Equity in net earnings (loss) of affiliates 29 51 51 106  
Capital expenditures 84 [3] 87 [3] 162 [4] 192 [4]  
Goodwill and intangible assets, net 9,238   9,238   $ 9,028
Total assets 23,713   23,713   22,857
Increase (decrease) in accrued capital expenditures (9) (18) (33) (50)  
Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 1,442 1,467 2,729 2,845  
Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales [5] 1,090 1,184 2,192 2,417  
Operating Segments | Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 1,442 1,467 2,729 2,845  
Cost of sales (1,097) (1,110) (2,109) (2,219)  
Gross profit 345 357 620 626  
Selling, general and administrative expenses (100) (109) (207) (212)  
Amortization of intangible assets (41) (38) (81) (78)  
Research and development expenses (21) (23) (42) (48)  
Other (charges) gains, net (Note 18) (16) (43) (31) (54)  
Gain (loss) on disposition of business and assets, net (2) (6) 2 (7)  
Other segment items(2) 0 [2] 0 [1] 0 [2] 0 [2]  
Operating profit (loss) 165 138 261 227  
Depreciation and amortization 114 121 223 268  
Equity in net earnings (loss) of affiliates 24 47 40 96  
Capital expenditures 46 41 85 78  
Goodwill and intangible assets, net 8,799   8,799   8,617
Total assets 15,868   15,868   15,496
Operating Segments | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales 1,115 1,202 2,231 2,463  
Cost of sales (925) (919) (1,839) (1,885)  
Gross profit 190 283 392 578  
Selling, general and administrative expenses (23) (28) (50) (58)  
Amortization of intangible assets (1) 0 (1) (1)  
Research and development expenses (10) (10) (20) (20)  
Other (charges) gains, net (Note 18) (1) (1) (4) (1)  
Gain (loss) on disposition of business and assets, net (1) (2) (1) (2)  
Other segment items(2) 0 [2] 0 [1] 0 [2] 0 [2]  
Operating profit (loss) 154 242 316 496  
Depreciation and amortization 64 61 125 118  
Equity in net earnings (loss) of affiliates 2 3 5 5  
Capital expenditures 32 36 62 76  
Goodwill and intangible assets, net 439   439   411
Total assets 5,488   5,488   5,265
Segment Reporting, Reconciling Item, Corporate Nonsegment | Corporate Segment and Other Operating Segment [Member]          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 0  
Cost of sales 0 1 (1) (9)  
Gross profit 0 1 (1) (9)  
Selling, general and administrative expenses (90) (118) (186) (250)  
Amortization of intangible assets 0 0 0 0  
Research and development expenses 0 0 0 1  
Other (charges) gains, net (Note 18) (3) (4) (16) (7)  
Gain (loss) on disposition of business and assets, net 1 0 0 0  
Other segment items(2) 6 [1] (9) [1] 27 [2] 2 [2]  
Operating profit (loss) (86) (130) (176) (263)  
Depreciation and amortization 12 10 22 27  
Equity in net earnings (loss) of affiliates 3 1 6 5  
Capital expenditures 6 10 15 38  
Goodwill and intangible assets, net 0   0   0
Total assets 2,357   2,357   2,096
Eliminations          
Segment Reporting Information [Line Items]          
Net sales (25) [6] (18) [6] (39) [7] (46) [7]  
Cost of sales 25 18 39 46  
Gross profit 0 0 0 0  
Selling, general and administrative expenses 0 0 0 0  
Amortization of intangible assets 0 0 0 0  
Research and development expenses 0 0 0 0  
Other (charges) gains, net (Note 18) 0 0 0 0  
Gain (loss) on disposition of business and assets, net 0 0 0 0  
Other segment items(2) 0 [1] 0 [1] 0 [2] 0 [2]  
Operating profit (loss) 0 0 0 0  
Depreciation and amortization 0 0 0 0  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Capital expenditures 0 0 0 0  
Goodwill and intangible assets, net 0   0   0
Total assets 0   0   $ 0
Eliminations | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales $ 25 $ 18 $ 39 $ 46  
[1] Includes Foreign exchange gain (loss), net.
[2] Includes Foreign exchange gain (loss), net.
[3] Includes a decrease in accrued capital expenditures of $9 million and $18 million for the three months ended June 30, 2025 and 2024, respectively.
[4] Includes a decrease in accrued capital expenditures of $33 million and $50 million for the six months ended June 30, 2025 and 2024, respectively.
[5] Excludes intersegment sales of $25 million and $18 million for the three months ended June 30, 2025 and 2024, respectively. Excludes intersegment sales of $39 million and $46 million for the six months ended June 30, 2025 and 2024, respectively.
[6] Includes intersegment sales primarily related to the Acetyl Chain.
[7] Includes intersegment sales primarily related to the Acetyl Chain.